{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:15:59Z","timestamp":1787008559642,"version":"build-2736575974"},"reference-count":74,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1093\/brain\/awx053","type":"journal-article","created":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T15:13:27Z","timestamp":1487690007000},"page":"1371-1383","source":"Crossref","is-referenced-by-count":49,"title":["Neuroimaging and clinical features in adults with a 22q11.2 deletion at risk of Parkinson\u2019s disease"],"prefix":"10.1093","volume":"140","author":[{"given":"Nancy J.","family":"Butcher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie","family":"Marras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Pondal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Rusjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Boot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh","family":"Christopher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela M.","family":"Repetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemarie","family":"Fritsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva W. C.","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Masellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio P.","family":"Strafella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony E.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne S.","family":"Bassett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,3,24]]},"reference":[{"key":"key\n\t\t\t\t20170707103119_awx053-B1","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1093\/brain\/awh607","article-title":"PET in LRRK2 mutations: comparison to sporadic Parkinson\u2019s disease and evidence for presymptomatic compensation","volume":"128","year":"2005","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170707103119_awx053-B2","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1212\/WNL.55.9.1410","article-title":"Decreased striatal dopaminergic innervation in REM sleep behavior disorder","volume":"55","year":"2000","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170707103119_awx053-B3","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.biopsych.2006.07.038","article-title":"Catechol-O-methyl transferase and expression of schizophrenia in 73 adults with 22q11 deletion syndrome","volume":"61","year":"2007","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t20170707103119_awx053-B4","first-page":"307","article-title":"Clinical features of 78 adults with 22q11 deletion syndrome","volume":"138","year":"2005","journal-title":"Am J Med Genet A"},{"key":"key\n\t\t\t\t20170707103119_awx053-B5","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jpeds.2011.02.039","article-title":"Practical guidelines for managing patients with 22q11.2 deletion syndrome","volume":"159","year":"2011","journal-title":"J Pediatr"},{"key":"key\n\t\t\t\t20170707103119_awx053-B6","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00702-010-0469-5","article-title":"Hyperechogenicity of the substantia nigra: pitfalls in assessment and specificity for Parkinson\u2019s disease","volume":"118","year":"2011","journal-title":"J Neural Transm"},{"key":"key\n\t\t\t\t20170707103119_awx053-B7","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/mds.25192","article-title":"Enlarged hyperechogenic substantia nigra as a risk marker for Parkinson\u2019s disease","volume":"28","year":"2013","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20170707103119_awx053-B8","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/mds.26431","article-title":"MDS research criteria for prodromal Parkinson\u2019s disease","volume":"30","year":"2015","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20170707103119_awx053-B9","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1001\/archneur.59.6.999","article-title":"Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury","volume":"59","year":"2002","journal-title":"Arch Neurol"},{"key":"key\n\t\t\t\t20170707103119_awx053-B10","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/mds.25272","article-title":"Color discrimination deficits in Parkinson\u2019s disease are related to cognitive impairment and white-matter alterations","volume":"27","year":"2012","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20170707103119_awx053-B11","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1096\/fj.12-226852","article-title":"Dysfunction of dopamine homeostasis: clues in the hunt for novel Parkinson\u2019s disease therapies","volume":"27","year":"2013","journal-title":"FASEB J"},{"key":"key\n\t\t\t\t20170707103119_awx053-B12","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/sj.jcbfm.9600276","article-title":"Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease","volume":"26","year":"2006","journal-title":"J Cereb Blood Flow Metab"},{"key":"key\n\t\t\t\t20170707103119_awx053-B13","doi-asserted-by":"crossref","first-page":"9850","DOI":"10.1523\/JNEUROSCI.3008-08.2008","article-title":"Increased vesicular monoamine transporter binding during early abstinence in human methamphetamine users: is VMAT2 a stable dopamine neuron biomarker?","volume":"28","year":"2008","journal-title":"J Neurosci"},{"key":"key\n\t\t\t\t20170707103119_awx053-B14","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1002\/ajmg.a.33665","article-title":"Co-occurrence of early-onset Parkinson disease and 22q11.2 deletion syndrome: potential role for dopamine transporter imaging","volume":"152A","year":"2010","journal-title":"Am J Med Genet A"},{"key":"key\n\t\t\t\t20170707103119_awx053-B15","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1177\/0269881111400644","article-title":"Dopamine metabolism in adults with 22q11 deletion syndrome, with and without schizophrenia-relationship with COMT Val108\/158Met polymorphism, gender and symptomatology","volume":"25","year":"2011","journal-title":"J Psychopharm"},{"key":"key\n\t\t\t\t20170707103119_awx053-B16","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/sj.npp.1301508","article-title":"Disrupted dopaminergic neurotransmission in 22q11 deletion syndrome","volume":"33","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"key\n\t\t\t\t20170707103119_awx053-B17","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1177\/0269881109104854","article-title":"Striatal D2 receptor binding in 22q11 deletion syndrome: an [123I]IBZM SPECT study","volume":"24","year":"2010","journal-title":"J Psychopharm"},{"key":"key\n\t\t\t\t20170707103119_awx053-B18","first-page":"639","article-title":"Movement disorders and other motor abnormalities in adults with 22q11.2 deletion syndrome","volume":"167A","year":"2015","journal-title":"Am J Med Genet A"},{"key":"key\n\t\t\t\t20170707103119_awx053-B19","doi-asserted-by":"crossref","first-page":"e002613","DOI":"10.1136\/bmjopen-2013-002613","article-title":"Specificity and sensitivity of transcranial sonography of the substantia nigra in the diagnosis of Parkinson\u2019s disease: prospective cohort study in 196 patients","volume":"3","year":"2013","journal-title":"BMJ Open"},{"key":"key\n\t\t\t\t20170707103119_awx053-B20","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1212\/WNL.42.3.683","article-title":"Catechol-O-methyltransferase inhibition increases striatal L-dopa and dopamine: an in vivo study in rats","volume":"42","year":"1992","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170707103119_awx053-B21","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/gim.2012.66","article-title":"Functional outcomes of adults with 22q11.2 deletion syndrome","volume":"14","year":"2012","journal-title":"Genet Med"},{"key":"key\n\t\t\t\t20170707103119_awx053-B22","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jamaneurol.2013.3646","article-title":"Association between early-onset Parkinson disease and 22q11.2 deletion syndrome: identification of a novel genetic form of Parkinson disease and its clinical implications","volume":"70","year":"2013","journal-title":"JAMA Neurol"},{"key":"key\n\t\t\t\t20170707103119_awx053-B23","first-page":"283","article-title":"Reproducibility studies with 11C-DTBZ, a monoamine vesicular transporter inhibitor in healthy human subjects","volume":"40","year":"1999","journal-title":"J Nucl Med"},{"key":"key\n\t\t\t\t20170707103119_awx053-B24","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.schres.2006.04.007","article-title":"Neurocognitive profile in 22q11 deletion syndrome and schizophrenia","volume":"87","year":"2006","journal-title":"Schizophr Res"},{"key":"key\n\t\t\t\t20170707103119_awx053-B25","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/brain\/awt337","article-title":"Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson\u2019s disease with mild cognitive impairment","volume":"137","year":"2014","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170707103119_awx053-B26","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1093\/hmg\/ddt297","article-title":"Pathogenic rare copy number variants in community-based schizophrenia suggest a potential role for clinical microarrays","volume":"22","year":"2013","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t20170707103119_awx053-B27","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/syn.10199","article-title":"VMAT2 binding is elevated in dopa-responsive dystonia: visualizing empty vesicles by PET","volume":"49","year":"2003","journal-title":"Synapse"},{"key":"key\n\t\t\t\t20170707103119_awx053-B28","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/ana.410400609","article-title":"Presynaptic monoaminergic vesicles in Parkinson\u2019s disease and normal aging","volume":"40","year":"1996","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170707103119_awx053-B29","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/gim.2014.175","article-title":"Practical guidelines for managing adults with 22q11.2 deletion syndrome","volume":"17","year":"2015","journal-title":"Genet Med"},{"key":"key\n\t\t\t\t20170707103119_awx053-B30","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/schbul\/sbr111","article-title":"Striatal presynaptic dopamine in schizophrenia, part I: meta-analysis of dopamine active transporter (DAT) density","volume":"39","year":"2013","journal-title":"Schizophr Bull"},{"key":"key\n\t\t\t\t20170707103119_awx053-B31","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.pharmthera.2014.06.006","article-title":"Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disorders","volume":"144","year":"2014","journal-title":"Pharmacol Ther"},{"key":"key\n\t\t\t\t20170707103119_awx053-B32","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.schres.2007.07.021","article-title":"Developmental trajectories of brain structure in adolescents with 22q11.2 deletion syndrome: a longitudinal study","volume":"96","year":"2007","journal-title":"Schizophr Res"},{"key":"key\n\t\t\t\t20170707103119_awx053-B33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-1-4757-9480-9_13","article-title":"Reactive dopamine metabolites and neurotoxicity: implications for Parkinson\u2019s disease","volume":"387","year":"1996","journal-title":"Adv Exp Med Biol"},{"key":"key\n\t\t\t\t20170707103119_awx053-B34","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1046\/j.0953-816x.2001.01856.x","article-title":"Brain catecholamine metabolism in catechol-O-methyltransferase (COMT)-deficient mice","volume":"15","year":"2002","journal-title":"Eur J Neurosci"},{"key":"key\n\t\t\t\t20170707103119_awx053-B35","first-page":"S717","article-title":"A 3D atlas of the human brain","volume-title":"Neuroimage","year":"1998"},{"key":"key\n\t\t\t\t20170707103119_awx053-B36","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0014-4886(03)00096-7","article-title":"Treatment effects on nigrostriatal projection integrity in partial 6-OHDA lesions: comparison of L-DOPA and pramipexole","volume":"183","year":"2003","journal-title":"Exp Neurol"},{"key":"key\n\t\t\t\t20170707103119_awx053-B37","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0969-8051(96)00023-6","article-title":"Effects of dopaminergic drug treatments on in vivo radioligand binding to brain vesicular monoamine transporters","volume":"23","year":"1996","journal-title":"Nucl Med Biol"},{"key":"key\n\t\t\t\t20170707103119_awx053-B38","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1097\/00004647-199912000-00011","article-title":"Assessment of extrastriatal vesicular monoamine transporter binding site density using stereoisomers of [11C]dihydrotetrabenazine","volume":"19","year":"1999","journal-title":"J Cereb Blood Flow Metab"},{"key":"key\n\t\t\t\t20170707103119_awx053-B39","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1097\/00004647-199611000-00025","article-title":"Kinetic evaluation of [11C]dihydrotetrabenazine by dynamic PET: measurement of vesicular monoamine transporter","volume":"16","year":"1996","journal-title":"J Cereb Blood Flow Metab"},{"key":"key\n\t\t\t\t20170707103119_awx053-B40","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/nimg.1996.0066","article-title":"Simplified reference tissue model for PET receptor studies","volume":"4","year":"1996","journal-title":"Neuroimage"},{"key":"key\n\t\t\t\t20170707103119_awx053-B41","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.mam.2012.07.005","article-title":"SLC18: vesicular neurotransmitter transporters for monoamines and acetylcholine","volume":"34","year":"2013","journal-title":"Mol Aspects Med"},{"key":"key\n\t\t\t\t20170707103119_awx053-B42","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/gm566","article-title":"Genetics and genomics of Parkinson\u2019s disease","volume":"6","year":"2014","journal-title":"Genome Med"},{"key":"key\n\t\t\t\t20170707103119_awx053-B43","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neulet.2014.08.053","article-title":"The predictive value of transcranial sonography in clinically diagnosed patients with early stage Parkinson\u2019s disease: comparison with DAT PET scans","volume":"582","year":"2014","journal-title":"Neurosci Lett"},{"key":"key\n\t\t\t\t20170707103119_awx053-B44","doi-asserted-by":"crossref","first-page":"9977","DOI":"10.1073\/pnas.1402134111","article-title":"Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo","volume":"111","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170707103119_awx053-B45","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/mds.20389","article-title":"Smell identification ability in twin pairs discordant for Parkinson\u2019s disease","volume":"20","year":"2005","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20170707103119_awx053-B46","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1212\/WNL.0b013e318227042d","article-title":"Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers","volume":"77","year":"2011","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170707103119_awx053-B47","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/ana.21320","article-title":"Dihydrotetrabenazine positron emission tomography imaging in early, untreated Parkinson\u2019s disease","volume":"63","year":"2008","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170707103119_awx053-B48","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/01.WCB.0000048520.34839.1A","article-title":"Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum","volume":"23","year":"2003","journal-title":"J Cereb Blood Flow Metab"},{"key":"key\n\t\t\t\t20170707103119_awx053-B49","doi-asserted-by":"crossref","first-page":"15071","DOI":"10.1038\/nrdp.2015.71","article-title":"22q11.2 deletion syndrome","volume":"1","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"key\n\t\t\t\t20170707103119_awx053-B50","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S1474-4422(16)00071-5","article-title":"Deletions at 22q11.2 in idiopathic Parkinson\u2019s disease: a combined analysis of genome-wide association data","volume":"15","year":"2016","journal-title":"Lancet Neurol"},{"key":"key\n\t\t\t\t20170707103119_awx053-B51","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.sleep.2004.11.007","article-title":"The association between narcolepsy and REM behavior disorder (RBD)","volume":"6","year":"2005","journal-title":"Sleep Med"},{"key":"key\n\t\t\t\t20170707103119_awx053-B52","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11910-015-0566-9","article-title":"Developments in the role of transcranial sonography for the differential diagnosis of parkinsonism","volume":"15","year":"2015","journal-title":"Curr Neurol Neurosci Rep"},{"key":"key\n\t\t\t\t20170707103119_awx053-B53","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","year":"2015","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20170707103119_awx053-B54","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1093\/brain\/aws093","article-title":"How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder","volume":"135","year":"2012","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170707103119_awx053-B55","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1002\/mds.26305","article-title":"22q11.2 deletion syndrome presenting with early-onset Parkinson\u2019s disease","volume":"30","year":"2015","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20170707103119_awx053-B56","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.schres.2010.12.015","article-title":"Olfactory deficits in deletion syndrome 22q11.2","volume":"129","year":"2011","journal-title":"Schizophr Res"},{"key":"key\n\t\t\t\t20170707103119_awx053-B57","first-page":"904","article-title":"Correction for partial volume effects in PET: principle and validation","volume":"39","year":"1998","journal-title":"J Nucl Med"},{"key":"key\n\t\t\t\t20170707103119_awx053-B58","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.pscychresns.2006.01.011","article-title":"An automated method for the extraction of regional data from PET images","volume":"147","year":"2006","journal-title":"Psychiatry Res"},{"key":"key\n\t\t\t\t20170707103119_awx053-B59","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/mds.24954","article-title":"Premotor Parkinson\u2019s disease: concepts and definitions","volume":"27","year":"2012","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20170707103119_awx053-B60","doi-asserted-by":"crossref","first-page":"e697","DOI":"10.1542\/peds.2005-3114","article-title":"Olfactory disorder in children with 22q11 deletion syndrome","volume":"118","year":"2006","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t20170707103119_awx053-B61","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1002\/mds.23356","article-title":"Dopamine turnover increases in asymptomatic LRRK2 mutations carriers","volume":"25","year":"2010","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20170707103119_awx053-B62","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s13311-010-0007-z","article-title":"Neuroimaging in Parkinson\u2019s disease","volume":"8","year":"2011","journal-title":"Neurotherapeutics"},{"key":"key\n\t\t\t\t20170707103119_awx053-B63","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S1474-4422(11)70214-9","article-title":"Advances in imaging in Parkinson\u2019s disease","volume":"10","year":"2011","journal-title":"Lancet Neurol"},{"key":"key\n\t\t\t\t20170707103119_awx053-B64","doi-asserted-by":"crossref","first-page":"e49483","DOI":"10.1371\/journal.pone.0049483","article-title":"Dopamine D1, D2, D3 receptors, vesicular monoamine transporter type-2 (VMAT2) and dopamine transporter (DAT) densities in aged human brain","volume":"7","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170707103119_awx053-B65","volume-title":"Co-planar stereotaxic atlas of the human brain","year":"1988"},{"key":"key\n\t\t\t\t20170707103119_awx053-B66","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0893-133X(00)00165-2","article-title":"In vivo measurement of the vesicular monoamine transporter in schizophrenia","volume":"23","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"key\n\t\t\t\t20170707103119_awx053-B67","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1038\/jcbfm.2011.63","article-title":"Distribution of vesicular monoamine transporter 2 protein in human brain: implications for brain imaging studies","volume":"31","year":"2011","journal-title":"J Cereb Blood Flow Metab"},{"key":"key\n\t\t\t\t20170707103119_awx053-B68","first-page":"205ps20","article-title":"Parkinson\u2019s disease: from human genetics to clinical trials","volume":"7","year":"2015","journal-title":"Sci Transl Med"},{"key":"key\n\t\t\t\t20170707103119_awx053-B69","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/gim.2015.84","article-title":"Fetal growth and gestational factors as predictors of schizophrenia in 22q11.2 deletion syndrome","volume":"18","year":"2016","journal-title":"Genet Med"},{"key":"key\n\t\t\t\t20170707103119_awx053-B70","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/0306-4522(95)00167-H","article-title":"[3H]methoxytetrabenazine: a high specific activity ligand for estimating monoaminergic neuronal integrity","volume":"68","year":"1995","journal-title":"Neuroscience"},{"key":"key\n\t\t\t\t20170707103119_awx053-B71","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0028-3908(99)00210-5","article-title":"Reserpine or chronic paroxetine treatments do not modify the vesicular monoamine transporter 2 expression in serotonin-containing regions of the rat brain","volume":"39","year":"2000","journal-title":"Neuropharmacology"},{"key":"key\n\t\t\t\t20170707103119_awx053-B72","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nm0696-699","article-title":"Striatal dopamine nerve terminal markers in human, chronic methamphetamine users","volume":"2","year":"1996","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20170707103119_awx053-B73","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1212\/WNL.47.3.718","article-title":"Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson\u2019s disease","volume":"47","year":"1996","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170707103119_awx053-B74","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/ajmg.a.32650","article-title":"The co-occurrence of early onset Parkinson disease and 22q11.2 deletion syndrome","volume":"149A","year":"2009","journal-title":"Am J Med Genet A"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/140\/5\/1371\/18223513\/awx053.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T19:13:18Z","timestamp":1568833998000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article-lookup\/doi\/10.1093\/brain\/awx053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,24]]},"references-count":74,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,3,24]]},"published-print":{"date-parts":[[2017,5]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awx053","relation":{},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"value":"0006-8950","type":"print"},{"value":"1460-2156","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,24]]}}}